Several epidemiological and clinical studies have suggested a possible shared pathophysiology between diabetes and AD, and the administration of certain antidiabetic medications, such as intranasal insulin, metformin, incretins, and thiazolidinediones, has been shown to improve cognition and memory in patients with mild cognitive impairment and AD. The gene discussed is GCG; the disease is Alzheimer disease.